Why is Natco Pharma Ltd. ?
1
With a fall in Net Profit of -29.18%, the company declared Very Negative results in Sep 26
- The company has declared negative results for the last 4 consecutive quarters
- PAT(Q) At Rs 202.60 cr has Fallen at -29.2% (vs previous 4Q average)
- NET SALES(Latest six months) At Rs 1,702.50 cr has Grown at -36.75%
- ROCE(HY) Lowest at 7.27%
2
Stock is technically in a Mildly Bearish range
- A key technical factor - MACD has been Bearish since 06 Nov 2026
3
Below par performance in long term as well as near term
- Along with generating -5.26% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Natco Pharma for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Natco Pharma
-5.26%
-0.14
36.28%
Sensex
-2.0%
-0.13
14.98%
Quality key factors
Factor
Value
Sales Growth (5y)
15.95%
EBIT Growth (5y)
20.66%
EBIT to Interest (avg)
54.62
Debt to EBITDA (avg)
0.46
Net Debt to Equity (avg)
-0.05
Sales to Capital Employed (avg)
0.51
Tax Ratio
8.81%
Dividend Payout Ratio
5.70%
Pledged Shares
0.94%
Institutional Holding
26.18%
ROCE (avg)
21.71%
ROE (avg)
16.74%
Valuation Key Factors 
Factor
Value
P/E Ratio
19
Industry P/E
40
Price to Book Value
1.63
EV to EBIT
28.73
EV to EBITDA
21.14
EV to Capital Employed
1.66
EV to Sales
5.00
PEG Ratio
NA
Dividend Yield
0.66%
ROCE (Latest)
5.79%
ROE (Latest)
8.48%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Technical Movement
3What is working for the Company
OPERATING CF(Y)
Highest at Rs 1,776.40 Cr
-31What is not working for the Company
PAT(Q)
At Rs 202.60 cr has Fallen at -29.2% (vs previous 4Q average
NET SALES(Latest six months)
At Rs 1,702.50 cr has Grown at -36.75%
ROCE(HY)
Lowest at 7.27%
INVENTORY TURNOVER RATIO(HY)
Lowest at 3.07 times
DEBT-EQUITY RATIO(HY)
Highest at 0.11 times
INTEREST(Q)
Highest at Rs 17.60 cr
PBT LESS OI(Q)
At Rs 191.10 cr has Fallen at -5.6% (vs previous 4Q average
Loading Valuation Snapshot...
Here's what is working for Natco Pharma
Operating Cash Flow - Annually
Highest at Rs 1,776.40 Cr and Grown
each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (Rs Cr)
Here's what is not working for Natco Pharma
Profit After Tax (PAT) - Quarterly
At Rs 202.60 cr has Fallen at -29.2% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 286.08 CrMOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Interest - Quarterly
At Rs 17.60 cr has Grown at 35.38%
Quarter on Quarter (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Net Sales - Latest six months
At Rs 1,702.50 cr has Grown at -36.75%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
Inventory Turnover Ratio- Half Yearly
Lowest at 3.07 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Interest - Quarterly
Highest at Rs 17.60 cr
in the last five quarters and Increased by 35.38 % (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 191.10 cr has Fallen at -5.6% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 202.35 CrMOJO Watch
Near term PBT trend is negative
PBT less Other Income (Rs Cr)
Debt-Equity Ratio - Half Yearly
Highest at 0.11 times
in the last five half yearly periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio